Anti-inflammatory activities of isorhamnetin-3-O-galactoside against HMGB1-induced inflammatory responses in both HUVECs and CLP-induced septic mice

Journal of Cellular Biochemistry

Volumn 114, Issue 2, 2013, Pages 336-345

  Kim, Tae Hoon ^a   Ku, Sae Kwang ^a   Bae, Jong Sup ^b  

^a Daegu Haany University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Barrier integrity; HMGB1; Inflammation; Isorhamnetin 3 O galactoside; Sepsis

Indexed keywords

ANTIINFLAMMATORY AGENT; HIGH MOBILITY GROUP B1 PROTEIN; HYPERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISORHAMNETIN 3 O GALACTOSIDE; KAEMPFEROL 3 SOPHOROSIDE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE MIGRATION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SEPSIS;

ANIMALS; CELL MOVEMENT; DOWN-REGULATION; GALACTOSIDES; HMGB1 PROTEIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; LEUKOCYTES; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; QUERCETIN; SEPSIS; SIGNAL TRANSDUCTION;

MUS; OENANTHE CROCATA;

EID: 84872735026     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24361     Document Type: Article

References (49)

1. Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, Pandey MK, Shishodia S, Nair MG. 2006. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets 10:87-118.
2. Akeson AL, Woods CW. 1993. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J Immunol Methods 163:181-185.
3. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570.
4. Bae JW, Bae JS. 2011. Barrier protective effects of lycopene in human endothelial cells. Inflamm Res 60:751-758.
5. Bae JS, Rezaie AR. 2008. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost 100:101-109.
6. Bae JS, Rezaie AR. 2011. Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 118:3952-3959.
7. Bae JS, Yang L, Manithody C, Rezaie AR. 2007. Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties. J Biol Chem 282:9251-9259.
8. Buras JA, Holzmann B, Sitkovsky M. 2005. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4:854-865.
9. Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M, Glassman M, Lee JD, Yan C, Berk BC, Abe J. 2002. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res 90:1222-1230.
10. El Gazzar M. 2007. HMGB1 modulates inflammatory responses in LPS-activated macrophages. Inflamm Res 56:162-167.
11. Fisher M. 2008. Injuries to the vascular endothelium: vascular wall and endothelial dysfunction. Rev Neurol Dis 5 (suppl 1): S4-S11.
12. Friedl J, Puhlmann M, Bartlett DL, Libutti SK, Turner EN, Gnant MF, Alexander HR. 2002. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 100:1334-1339.
13. Goldblum SE, Ding X, Campbell-Washington J. 1993. TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am J Physiol 264:C894-C905.
14. Han YQ, Huang ZM, Yang XB, Liu HZ, Wu GX. 2008. In vivo and in vitro antihepatitis B virus activity of total phenolics from Oenanthe javanica. J Ethnopharmacol 118:148-153.
15. Hansson GK, Libby P. 2006. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508-519.
16. Hofbauer R, Moser D, Salfinger H, Frass M, Kapiotis S. 1998. Sufentanil inhibits migration of human leukocytes through human endothelial cell monolayers. Anesth Analg 87:1181-1185.
17. Huang W, Tang Y, Li L. 2010. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 51:119-126.
18. Ji G, Yao X, Zang Z, Huang Z. 1990. Antiarrhythmic effect of Oenanthe javanica (Bl.) DC. injection. Zhongguo Zhong Yao Za Zhi 15:429-431.
19. Kim TH, Bae JS. 2010. Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells. Food Chem Toxicol 48:1682-1687.
20. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. 2001. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614-7620.
21. Kim TH, Ku SK, Bae JS. 2012a. Inhibitory effects of kaempferol-3-O- sophoroside on HMGB1-mediated proinflammatory responses. Food Chem Toxicol 50:1118-1123.
22. Kim TH, Ku SK, Lee IC, Bae JS. 2012b. Anti-inflammatory effects of kaempferol-3-O-sophoroside in human endothelial cells. Inflamm Res 61: 217-224.
23. Lee W, Kim TH, Ku SK, Min KJ, Lee HS, Kwon TK, Bae JS. 2012. Barrier protective effects of with aferin A in HMGB1-induced inflammatory responses in both cellular and animal models. Toxicol Appl Pharmacol 262:91-98.
24. Liu X, Wang D, Wang SY, Meng XS, Zhang WJ, Ying XX, Kang TG. 2010. LC determination and pharmacokinetic study of hyperoside in rat plasma after intravenous administration. Yakugaku Zasshi 130:873-879.
25. Lockyer JM, Colladay JS, Alperin-Lea WL, Hammond T, Buda AJ. 1998. Inhibition of nuclear factor-kappaB-mediated adhesion molecule expression in human endothelial cells. Circ Res 82:314-320.
26. Ma CJ, Lee KY, Jeong EJ, Kim SH, Park J, Choi YH, Kim YC, Sung SH. 2010. Persicarin from water dropwort (Oenanthe javanica) protects primary cultured rat cortical cells from glutamate-induced neurotoxicity. Phytother Res 24:913-918.
27. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866-1874.
28. Materska M. 2008. Quercetin and its derivatives: chemical structure and bioactivity. Pol J Food Nutr Sci 58:407-413.
29. Mullins GE, Sunden-Cullberg J, Johansson AS, Rouhiainen A, Erlandsson-Harris H, Yang H, Tracey KJ, Rauvala H, Palmblad J, Andersson J, Treutiger CJ. 2004. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol 60:566-573.
30. Park JC, Yu YB, Lee JH. 1993. Isolation of steroids and flavonoids from the herb of Oenanthe javanica DC. Korean J Pharmacognosy 24:244-246.
31. Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ, Abraham E. 2003. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 284:C870-C879.
32. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E. 2004. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370-7377.
33. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD. 2003. The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol 28:574-581.
34. Radwan HM, Nazif NM, Abou-Setta LM. 2007. Phytochemical investigation of Salicornia fruticosa (L.) and their biological activity. Res J Med Med Sci 2: 72-78.
35. Schnittler HJ, Schneider SW, Raifer H, Luo F, Dieterich P, Just I, Aktories K. 2001. Role of actin filaments in endothelial cell-cell adhesion and membrane stability under fluid shear stress. Pflugers Arch 442:675-687.
36. Seo WH, Baek HH. 2005. Identification of characteristic aroma-active compounds from water dropwort (Oenanthe javanica DC.). J Agric Food Chem 53:6766-6770.
37. Sikorska M, Matlawska I. 2001. Kaempferol, isorhamnetin and their glycosides in the flowers of Asclepias syriaca L. Acta Pol Pharm 58:269-272.
38. Silva E, Arcaroli J, He Q, Svetkauskaite D, Coldren C, Nick JA, Poch K, Park JS, Banerjee A, Abraham E. 2007. HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury. Intensive Care Med 33:1829-1839.
39. Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H, Tracey KJ, Andersson J, Palmblad JE. 2003. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 254:375-385.
40. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ. 2002. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99:12351-12356.
41. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
42. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. 2001. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 164:1768-1773.
43. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Metz C, Miller EJ, Tracey KJ, Ulloa L. 2004a. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221.
44. Wang H, Yang H, Tracey KJ. 2004b. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 255:320-331.
45. Wolfson RK, Chiang ET, Garcia JG. 2011. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvasc Res 81:189-197.
46. Yang H, Tracey KJ. 2010. Targeting HMGB1 in inflammation. Biochim Biophys Acta 1799:149-156.
47. Yang XB, Huang ZM, Cao WB, Zheng M, Chen HY, Zhang JZ. 2000. Antidiabetic effect of Oenanthe javanica flavone. Acta Pharmacol Sin 21: 239-242.
48. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ. 2004. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 101: 296-301.
49. Yang H, Wang H, Czura CJ, Tracey KJ. 2005. The cytokine activity of HMGB1. J Leukoc Biol 78:1-8.